Mulmit

Aclaris Therapeutics, Inc.Aclaris Therapeutics, Inc.

ACRS Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-317,826,000-76,375,000-64,923,000-0.53
2024-12-3118,720,000-141,932,000-132,065,000-1.71
2023-12-3131,249,000-97,357,000-88,481,000-1.27
2022-12-3129,752,000-89,854,000-86,908,000-1.33
2021-12-316,761,000-89,723,000-90,865,000-1.6

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-01Kolbeck Roland WilhelmChief Scientific Officer36,375
2026-08-01Kolbeck Roland WilhelmChief Scientific Officer12,385
2026-08-01Kolbeck Roland WilhelmChief Scientific Officer36,375
2026-06-05Humphries William D.11,580
2026-06-05Humphries William D.11,580
2026-06-05Molineaux Christopher P.11,580
2026-06-05Molineaux Christopher P.11,580
2026-06-05Mehra Anand11,580
2026-06-05Mehra Anand11,580
2026-06-05GOWEN MAXINE11,580
2026-06-05GOWEN MAXINE11,580
2026-06-05MILANO VINCENT11,580

8-K events

FiledItems
2026-08-06Entry into a material agreement · Financial statements and exhibits
2026-08-06Results of operations · Financial statements and exhibits
2026-06-04Submission of matters to a vote
2026-05-07Results of operations · Financial statements and exhibits
2026-04-28Regulation FD disclosure · Other events · Financial statements and exhibits
2026-03-11Regulation FD disclosure
2026-03-10Regulation FD disclosure
2026-02-26Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.